Artivion Inc (AORT) financials
Artivion revenue and earnings by year
Artivion's revenue was $441 million in the fiscal year to December 31, 2025, up 13.6% from the year before. Net income was $9.77 million, 2.2% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 10.5% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 441 | 389 | 354 | 314 | 299 | 253 | 276 | 263 | 190 | 180 |
| Revenue growth | 13.6% | 9.8% | 12.8% | 5.0% | 18.0% | -8.3% | 5.1% | 38.6% | 5.2% | — |
| Gross profit | 284 | 249 | 229 | 203 | 198 | 168 | 183 | 173 | 129 | 119 |
| Gross margin | 64.4% | 64.0% | 64.7% | 64.5% | 66.1% | 66.3% | 66.3% | 65.8% | 67.8% | 65.9% |
| Operating income | 27 | 39 | -9 | 6 | -8 | 2 | 17 | 9 | 8 | 14 |
| Operating margin | 6.1% | 10.0% | -2.4% | 2.0% | -2.6% | 1.0% | 6.2% | 3.5% | 4.2% | 7.7% |
| Net income | 10 | -13 | -31 | -19 | -15 | -17 | 2 | -3 | 4 | 11 |
| Net margin | 2.2% | -3.4% | -8.7% | -6.1% | -5.0% | -6.6% | 0.6% | -1.1% | 2.0% | 6.0% |
| Diluted EPS | $0.21 | -$0.32 | -$0.75 | -$0.48 | -$0.38 | -$0.44 | $0.04 | -$0.08 | $0.10 | $0.33 |
| Free cash flow | 1 | 11 | 9 | -16 | -16 | 5 | 8 | 4 | 4 | 14 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open AORT in Markets.
How Artivion makes money
Revenue by segment in the quarter to June 30, 2026, as the company reports it.
| Segment | Revenue | Share |
|---|---|---|
| Aortic Stent Grafts | $46.4M | 36.9% |
| On X | $30.5M | 24.3% |
| Preservation Services | $25.9M | 20.6% |
| Surgical Sealants | $19.3M | 15.3% |
| Other Products | $3.70M | 2.9% |
See also: AORT valuation and P/E history · AORT returns
No forecast, no recommendation. This page describes Artivion Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.